Transient elevation of ribonucleotide reductase activity, M2 mRNA and M2 protein in BALB/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate
- PMID: 2669751
- DOI: 10.1016/0006-291x(89)90832-2
Transient elevation of ribonucleotide reductase activity, M2 mRNA and M2 protein in BALB/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate
Abstract
A rapid elevation of ribonucleotide reductase activity was observed with BALB/c 3T3 fibroblasts within 1/2 to 1 hour treatment with 0.1 microM 12-O-tetradecanoylphorbol-13-acetate (TPA). This increase in activity was transient, and returned to about normal levels within 24 to 48 hours. Northern analysis of the two components of ribonucleotide reductase showed a slight transient elevation of M1 mRNA and a marked transient elevation of M2 mRNA after 1/2 hour TPA treatment. As a positive control, ornithine decarboxylase message levels were also observed to be transiently elevated following identical treatment with TPA. Western blot analysis with M1 and M2 specific monoclonal antibodies indicated that the increase in ribonucleotide reductase activity was primarily due to the transient elevation of the M2 but not the M1 protein during treatment with 0.1 microM TPA. This first demonstration that the tumor promotor, TPA, can cause rapid and transient alterations in ribonucleotide reductase suggests that the enzyme, particularly the M2 component, may play an important role in the critical events involved in the process of tumor promotion.
Similar articles
-
Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent.J Biol Chem. 1992 Apr 5;267(10):7066-71. J Biol Chem. 1992. PMID: 1551913
-
Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.J Cell Physiol. 1992 Sep;152(3):529-35. doi: 10.1002/jcp.1041520312. J Cell Physiol. 1992. PMID: 1506411
-
Mammalian drug resistant mutants with multiple gene amplifications: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin and the L-subunit of ferritin.Biochim Biophys Acta. 1990 Oct 23;1087(2):165-72. doi: 10.1016/0167-4781(90)90201-c. Biochim Biophys Acta. 1990. PMID: 2223878
-
Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).Int J Oncol. 2003 Jan;22(1):21-31. Int J Oncol. 2003. PMID: 12469181 Review.
-
Ribonucleotide reductase--new twists in an old tale.Adv Enzyme Regul. 1989;28:113-23. doi: 10.1016/0065-2571(89)90067-8. Adv Enzyme Regul. 1989. PMID: 2696342 Review.
Cited by
-
Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3' untranslated region.EMBO J. 1993 Oct;12(10):3977-86. doi: 10.1002/j.1460-2075.1993.tb06075.x. EMBO J. 1993. PMID: 8404864 Free PMC article.
-
Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.Clin Exp Metastasis. 1998 Jan;16(1):43-9. doi: 10.1023/a:1006559901771. Clin Exp Metastasis. 1998. PMID: 9502076
-
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility.J Cell Biol. 1992 Jun;117(6):1343-50. doi: 10.1083/jcb.117.6.1343. J Cell Biol. 1992. PMID: 1376732 Free PMC article.
-
A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability.Nucleic Acids Res. 1993 Oct 11;21(20):4803-9. doi: 10.1093/nar/21.20.4803. Nucleic Acids Res. 1993. PMID: 8233829 Free PMC article.
-
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.Cancer Chemother Pharmacol. 2009 Nov;64(6):1149-55. doi: 10.1007/s00280-009-0977-x. Epub 2009 Mar 26. Cancer Chemother Pharmacol. 2009. PMID: 19322566 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials